Menu
GeneBe

rs1675126

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1

The NM_001040694.2(INCENP):c.1188T>C(p.Asn396=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.885 in 1,613,082 control chromosomes in the GnomAD database, including 639,712 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.88 ( 59570 hom., cov: 33)
Exomes 𝑓: 0.89 ( 580142 hom. )

Consequence

INCENP
NM_001040694.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.62
Variant links:
Genes affected
INCENP (HGNC:6058): (inner centromere protein) In mammalian cells, 2 broad groups of centromere-interacting proteins have been described: constitutively binding centromere proteins and 'passenger,' or transiently interacting, proteins (reviewed by Choo, 1997). The constitutive proteins include CENPA (centromere protein A; MIM 117139), CENPB (MIM 117140), CENPC1 (MIM 117141), and CENPD (MIM 117142). The term 'passenger proteins' encompasses a broad collection of proteins that localize to the centromere during specific stages of the cell cycle (Earnshaw and Mackay, 1994 [PubMed 8088460]). These include CENPE (MIM 117143); MCAK (MIM 604538); KID (MIM 603213); cytoplasmic dynein (e.g., MIM 600112); CliPs (e.g., MIM 179838); and CENPF/mitosin (MIM 600236). The inner centromere proteins (INCENPs) (Earnshaw and Cooke, 1991 [PubMed 1860899]), the initial members of the passenger protein group, display a broad localization along chromosomes in the early stages of mitosis but gradually become concentrated at centromeres as the cell cycle progresses into mid-metaphase. During telophase, the proteins are located within the midbody in the intercellular bridge, where they are discarded after cytokinesis (Cutts et al., 1999 [PubMed 10369859]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 11-62138902-T-C is Benign according to our data. Variant chr11-62138902-T-C is described in ClinVar as [Benign]. Clinvar id is 1261519.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.62 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.916 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
INCENPNM_001040694.2 linkuse as main transcriptc.1188T>C p.Asn396= synonymous_variant 7/19 ENST00000394818.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
INCENPENST00000394818.8 linkuse as main transcriptc.1188T>C p.Asn396= synonymous_variant 7/191 NM_001040694.2 P2Q9NQS7-1
INCENPENST00000278849.4 linkuse as main transcriptc.1188T>C p.Asn396= synonymous_variant 7/185 A2Q9NQS7-2
INCENPENST00000528375.1 linkuse as main transcriptn.157T>C non_coding_transcript_exon_variant 4/83

Frequencies

GnomAD3 genomes
AF:
0.879
AC:
133634
AN:
152082
Hom.:
59517
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.904
Gnomad AMI
AF:
0.954
Gnomad AMR
AF:
0.929
Gnomad ASJ
AF:
0.945
Gnomad EAS
AF:
0.468
Gnomad SAS
AF:
0.719
Gnomad FIN
AF:
0.730
Gnomad MID
AF:
0.953
Gnomad NFE
AF:
0.912
Gnomad OTH
AF:
0.906
GnomAD3 exomes
AF:
0.842
AC:
211370
AN:
251046
Hom.:
91209
AF XY:
0.839
AC XY:
113950
AN XY:
135738
show subpopulations
Gnomad AFR exome
AF:
0.906
Gnomad AMR exome
AF:
0.893
Gnomad ASJ exome
AF:
0.950
Gnomad EAS exome
AF:
0.456
Gnomad SAS exome
AF:
0.745
Gnomad FIN exome
AF:
0.742
Gnomad NFE exome
AF:
0.913
Gnomad OTH exome
AF:
0.888
GnomAD4 exome
AF:
0.886
AC:
1294621
AN:
1460880
Hom.:
580142
Cov.:
39
AF XY:
0.882
AC XY:
641334
AN XY:
726814
show subpopulations
Gnomad4 AFR exome
AF:
0.907
Gnomad4 AMR exome
AF:
0.898
Gnomad4 ASJ exome
AF:
0.947
Gnomad4 EAS exome
AF:
0.442
Gnomad4 SAS exome
AF:
0.748
Gnomad4 FIN exome
AF:
0.751
Gnomad4 NFE exome
AF:
0.917
Gnomad4 OTH exome
AF:
0.878
GnomAD4 genome
AF:
0.879
AC:
133746
AN:
152202
Hom.:
59570
Cov.:
33
AF XY:
0.866
AC XY:
64438
AN XY:
74394
show subpopulations
Gnomad4 AFR
AF:
0.904
Gnomad4 AMR
AF:
0.929
Gnomad4 ASJ
AF:
0.945
Gnomad4 EAS
AF:
0.467
Gnomad4 SAS
AF:
0.719
Gnomad4 FIN
AF:
0.730
Gnomad4 NFE
AF:
0.912
Gnomad4 OTH
AF:
0.906
Alfa
AF:
0.914
Hom.:
77898
Bravo
AF:
0.894
Asia WGS
AF:
0.652
AC:
2271
AN:
3478
EpiCase
AF:
0.922
EpiControl
AF:
0.925

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMay 04, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
Cadd
Benign
0.11
Dann
Benign
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1675126; hg19: chr11-61906374; COSMIC: COSV53913818; COSMIC: COSV53913818; API